Moxetumomab Pasudotox-tdfk Injection

Anter

• Ma mua o ka loaʻa ʻana o ka moxetumomab pasudotox-tdfk injection,
• Hoʻokumu paha ʻo Moxetumomab pasudotox-tdfk i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻARlelo AOAO IMAHI a i ʻole KĀʻĀLĀ ʻĀpana, e kāhea koke aku i kāu kauka a i ʻole e kiʻi i nā lāʻau lapaʻau pilikia.

Moxetumomab pasudotox-tdfk injection hiki ke kumu i kahi hopena koʻikoʻi a hoʻoweliweli paha i kapa ʻia ʻo capillary leak syndrome (kahi ʻano e hoʻonui ai i ka wai i loko o ke kino, ke kahe o ke koko haʻahaʻa, a me nā haʻahaʻa haʻahaʻa o kahi protein [albumin] i loko o ke koko). Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e kāhea koke aku i kāu kauka: ka pehu ʻana o ka maka, nā lima, nā wāwae, nā kuʻekuʻe wāwae, a me nā wāwae lalo; loaʻa ke kaupaona; pokole o ka hanu; uā; maule ana; ʻūpī a uila ʻole paha; aiʻole ka puʻuwai puʻuwai wikiwiki a i ʻole kaulike.

Moxetumomab pasudotox-tdfk injection hiki ke kumu i ka hemolytic uremic syndrome (kahi kūlana weliweli loa e pili ana i ka hōʻeha i nā hunaola ʻulaʻula, e hana ana i nā pilikia anemia a me nā puʻupaʻa). E haʻi i kāu kauka inā loaʻa ʻoe a i ʻole loaʻa i ka maʻi puʻupaʻa. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e haʻi koke aku i kāu kauka: ʻulaʻula a me nā noho koko a i ʻole diarrhea. hoʻemi i ka urination; ke koko i ka mimi; nā hoʻololi i ka naʻau a me nā ʻano hana; ka hopu ʻana; huikau; pokole o ka hanu; ka pehu o ka maka, nā lima, nā lima, nā wāwae, nā kuʻekuʻe wāwae, a me nā wāwae lalo; kahe koko ʻole a ʻeha paha; ʻeha ka ʻōpū; ka luaʻi; kuni; ʻili mae; a luhi paha a nawaliwali paha.

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E kauoha paha kāu kauka i kekahi mau hoʻokolohua ma mua, i ka wā, a ma hope o kāu mālama ʻana e nānā i ka pane o kou kino i ka moxetumomab pasudotox-tdfk injection.

E hāʻawi aku kāu kauka a mea kauka paha iā ʻoe i ka palapala ʻike hoʻomanawanui o ka mea hana (Kauka Lapaʻau) ke hoʻomaka ʻoe i ka mālama ʻana me ka moxetumomab pasudotox-tdfk injection a i kēlā me kēia manawa e hoʻopiha hou i kāu kuhikuhi. E heluhelu pono i ka ʻike a nīnau i kāu kauka a kauka paha inā he nīnau kāu. Hiki iā ʻoe ke kipa aku i ka pūnaewele ʻo Food and Drug Administration (FDA) (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) a i ʻole pūnaewele o ka mea hana e kiʻi i ka Medication Guide.

Hoʻohana ʻia ʻo Moxetumomab pasudotox-tdfk injection e mālama ai i ka leukemia huluhulu (maʻi ʻaʻai o kekahi ʻano o ke koko keʻokeʻo) i hoʻi mai a ʻaʻole i pane ʻia ma hope o ʻelua mau lāʻau ʻē aʻe. Aia ʻo Moxetumomab pasudotox-tdfk injection i loko o ka papa o nā lāʻau i kapa ʻia he monoclonal antibodies. Hana ia ma ke kōkua ʻana i kāu ʻōnaehana pale e hoʻolohi a kū i ka ulu ʻana o nā hunaola maʻi ʻaʻai.

Moxetumomab pasudotox-tdfk injection hele mai me he pauka e hui me ka wai a injected i loko o ke aa e kekahi kauka a kahu i loko o ka 'inikua keʻena a haukapila. Hoʻokomo pinepine ʻia ia ma kahi o 30 mau minuke i nā lā 1, 3, a me 5 o kahi pōʻaiapuni 28 mau lā. Hiki ke hana hou i kēia pōʻai a i 6 mau pōʻaiapuni. Pili ka lōʻihi o ka mālama ʻana i ka maikaʻi o ka pane ʻana o kou kino i ka lāʻau a me nā hopena ʻē aʻe āu e ʻike ai.

I kāu wā e mālama ai, e noi ana kāu kauka iā ʻoe e inu a ʻumikūmālua mau aniani 8-oz o nā wai e like me ka wai, waiū a wai wai paha i kēlā me kēia 24 hola i nā lā 1 a 8 o kēlā me kēia pōʻaiapuni lā he 28 mau lā.

Hoʻokumu paha ʻo Moxetumomab i nā hopena koʻikoʻi i ka manawa a ma hope paha o kou loaʻa ʻana i kāu infusion. Hāʻawi ʻia ʻoe i nā lāʻau i 30 a 90 mau minuke ma mua o kou hoʻokomo a ma hope o kāu hoʻopili ʻana e kōkua i ka pale ʻana i nā hopena i ka moxetumomab. Pono paha kāu kauka e hōʻoki i kāu lāʻau inā ʻike ʻoe i kekahi hopena ʻaoʻao. E haʻi i kāu kauka inā ʻike ʻoe i kekahi o kēia mau ʻōuli: puʻupuʻu, maʻule, maʻuleʻeha a paʻakikī paha i ka hanu ʻana, ka hanu ʻana o ka hanu, ka puʻuwai wikiwiki, ka ʻehaʻeha, kaʻi nui, ka luaʻi, ke poʻo poʻo, ke kuni, ke anu, ka ʻū, maʻule, hoʻomālamalama wela, a i ʻole ka holoi . He mea nui iā ʻoe e haʻi i kāu kauka i kou ʻano i kou wā e mālama ai me ka injection o moxetumomab pasudotox-tdfk. Kāhea koke i kāu kauka a i ʻole e kiʻi koke i ka lāʻau olakino pilikia inā ʻike ʻoe i kekahi o kēia mau ʻōuli ma hope o kou haʻalele ʻana i ke keʻena o kāu kauka a i ʻole kahi keʻena olakino.

Hiki i kāu kauka ke hōʻemi i kāu lāʻau, hoʻolohi a hoʻopau paha i kāu mālama ʻana me ka moxetumomab pasudotox-tdfk injection, a i ʻole mālama iā ʻoe me nā lāʻau hou aʻe e like me kāu pane i ka lāʻau a me nā hopena ʻē aʻe āu e ʻike ai. E kamaʻilio me kāu kauka e pili ana i kou ʻano i kāu mālama ʻana.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka loaʻa ʻana o ka moxetumomab pasudotox-tdfk injection,

• e haʻi i kāu kauka a me ka kauka inā he maʻi ʻoe i ka moxetumomab, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea i loko o ka moxetumomab pasudotox-tdfk injection. E noi i kāu kauka lāʻau a nānā i ke alakaʻi lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka inā loaʻa a loaʻa paha iā ʻoe kahi pilikia olakino.
• e haʻi i kāu kauka inā hāpai ʻoe a i ʻole hoʻolālā e hāpai. Pono ʻoe e hana i kahi hōʻike hāpai ma mua o kou hoʻomaka ʻana i ka moxetumomab. ʻAʻole ʻoe e hāpai ma ke kiʻi ʻana i ka moxetumomab pasudotox-tdfk injection a no 30 mau lā ma hope o kāu hopena hope loa. E kamaʻilio me kāu kauka e pili ana i nā hana kaohi hānau e holo pono nāu. Inā hāpai ʻoe i ka loaʻa ʻana o ka moxetumomab pasudotox-tdfk injection, e kelepona koke i kāu kauka. Hiki paha i ka Moxetumomab pasudotox-tdfk injection ke hōʻeha i ka fetus.
• e haʻi i kāu kauka inā e hānai ana ʻoe i ka waiū a i ʻole hoʻolālā e hānai.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Inā haʻalele ʻoe i kahi manawa e loaʻa ai kahi infusion, e kāhea koke i kāu kauka e hoʻoponopono hou i kāu manawa i koho ai.

Hoʻokumu paha ʻo Moxetumomab pasudotox-tdfk i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• kōpaʻa
• ʻili mae
• luhi
• ʻeha o ka maka a maloʻo paha
• pehu ka maka a maʻi paha
• loli ka hihiʻo

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻARlelo AOAO IMAHI a i ʻole KĀʻĀLĀ ʻĀpana, e kāhea koke aku i kāu kauka a i ʻole e kiʻi i nā lāʻau lapaʻau pilikia.

• ʻūpī mākala; numbness a i ʻole ʻūlū ʻana; kuʻi ʻole a i ʻole wikiwiki ka puʻuwai; nausea; aiʻole ka hopu ʻana

Hoʻokumu paha ʻo Moxetumomab pasudotox-tdfk i nā hopena ʻē aʻe. Kāhea i kāu kauka inā loaʻa iā ʻoe kekahi pilikia maʻamau i ka loaʻa ʻana o kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka moxetumomab pasudotox-tdfk injection.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• Lumoxiti^®